Europe News
AstraZeneca profit rises 23% as cancer medicines drive growth and savings plan begins
AstraZeneca’s third-quarter profit rose 23% as cancer-drug sales grew, while the company announced a $1.5bn annual savings plan.
AstraZeneca’s third-quarter profit rose 23% as cancer-drug sales grew, while the company announced a $1.5bn annual savings plan.
BP’s quarterly profit quadrupled as Iran war disruptions lifted oil prices and refining margins, while net debt fell…
HSBC reported sharply higher first-half profit, resumed share buybacks and pushed ahead with restructuring and asset sales.

Subscribe to DailyDigest notifications for the latest news and updates.